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Abstract Amoebapore is a 77-residue pore-forming peptide from Entamoeba histolytica with antibacterial and cytolytic properties. It contains eight 
lysine residues and one histidine residue. Chemical modifications of amoebapore with various reagents affecting either both types of cationic residues 
or lysine and histidine residues separately resulted in virtually complete loss of pore-forming activity. The activity was restored by reversal of 
modifications. Whereas amoebapore was no longer capable of binding to phospholipid vesicles when its Iysine residues were modified, the modification 
of the single histidine primarily affected oligomerization of the peptide upon membrane association. 
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1. Introduction 
The most prominent pathogenic feature of the protozoan 
parasite Entamoeba histolytica is the powerful ability to kill 
eukaryotic cells, which may result in massive tissue destruction 
in the human host [l]. In vitro, the killing event itself is rapid, 
contact dependent, and potentially directed against almost all 
cells [2,3]. The primary candidate for mediating the extraordi- 
nary cytolytic activity of E. rhistolytica is a peptide that forms 
ion channels in phospholipid membranes (for review see [4]). 
The peptide, named amoebapore, was purified from amoebic 
extracts [5] and its primary and secondary structure elucidated 
[6]. Amoebapore consists of 77 amino acid residues and has an 
all-a-helical conformation. The purified peptide was found to 
be cytotoxic to human cell lines and also to kill Gram-positive 
bacteria by permeabilizing their cytoplasmic membranes [7]. 
Biophysical data from planar lipid bilayer experiments [8] 
indicated that amoebapore creates ion channels in membranes 
by oligomerization according to the ‘barrel stave’ model [9]. 
Stable transmembrane pores inserted into a cell membrane 
would affect its function as a permeability barrier and may 
eventually result in lysis of the target cell. Amoebapore is pre- 
dicted to be composed of four mostly amphipathic helices and 
is stabilized by three disulfide bonds, providing a relatively rigid 
structure [6,10]. Synthetic peptides corresponding to the struc- 
tural elements proposed to permeate membranes, i.e. the am- 
phipathic helices 1 and 3, exhibited pore-forming activity [7]. 
In addition to amphipathic domains, positively charged resi- 
dues are considered critical for membranolytic peptides [11,121. 
This is reflected by selective binding of many of such molecules 
to negatively charged phospholipids, and by their increased 
activity at low pH ([11,13] and references therein). Likewise, 
amoebapore was found to insert preferentially in liposomes 
composed of acidic phospholipids and to be optimally active 
at pH 5.2 [5]. The peptide contains nine positively charged 
residues that might be crucial for activity, i.e. eight lysine resi- 
dues interspersed along the entire sequence and one histidine 
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residue near the C terminus (Fig. 1). Amoebapore does not 
possess any arginine residues. 
Here we describe the reversible inhibition of the pore-form- 
ing activity of amoebapore by chemical modification of its 
lysine residues and of its single histidine residue. Furthermore, 
we try to link the effects of both modifications to two steps that 
may be studied separately when a peptide forms a pore through 
the barrel stave mechanism, i.e. membrane association (bind- 
ing/insertion) and self-assembly. 
2. Materials and methods 
2. I. Chemicals 
Trifluoroacetic acid and acetonitrile, both of HPLC grade, were 
obtained from Applied biosystems. Diethylpyrocarbonate (DEPC), 
citraconic anhydride, and mixed phospholipids (phosphatidylcholin 
type II-S) from soybean are products from Sigma. Dithio- 
bis(succinimidylpropionate) (DSP) was from Pierce, and manoalide 
was from Biomol. Other chemicals were purchased from Merck and 
were of analysis grade. 
2.2. Purt$cation of amoebapore 
Amoebapore was purified from pathogenic E. histolytica strain HM- 
1:IMSS essentially as described [5]. Final purification was achieved by 
reverse-phase high-performance liquid chromatography using an Aq- 
uapore Butyl300 column (2.1 x 220 mm; Brownlee) connected to a 130 
A separation system (Applied biosystems). Elution was done with a 
linear gradient of O-70% acetonitrile in water acidified with 0.1% tri- 
fluoroacetic acid. The flow rate was 250 @min, and the eflluent was 
monitored by absorbance at 214 nm. Fractions of 250~1 were collected 
and assayed for pore-forming activity. Active fractions corresponding 
to a single peak were pooled and apparent homogeneity was confirmed 
by Tricine-SDS/PAGE. Purified peptide was lyophilized and stored at 
-20°C. 
2.3. Assay for pore-forming activity 
Pore-forming activity was determined by monitoring the dissipation 
of a valinomycin-induced iffusion potential in liposomes [5]. 
2.4. Modification with DEPC 
Reaction of amoebapore (5 PM) with DEPC was performed essen- 
tially according to Miles [14]. Briefly, amoebapore was dissolved in 
50 mM sodium phosphate buffer, pH 6.0 or 8.5. DEPC was added from 
a freshly prepared stock solution in anhydrous ethanol to reach a final 
concentration of 1 mM. The mixture was allowed to react for 1 h at 
20°C. Aliquots were taken at different time intervals to measure their 
pore-forming activity. 
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2.5. Reversal of DEPC modification by treatment with hydroxylamine 
DEPC-treated amoebapore (5 ,uM) was dialyzed against 100 mM 
sodium phosphate buffer, pH 7.0, in tubings with a molecular weight 
cut-off of 1,000 (Spectra/Par 6; Spectrum Industries, Los Angeles). 
Subsequently, hydroxylamine (adjusted with KOH to pH 7.0) was 
added to modified amoebapore to reach a final concentration of 0.8 M, 
and the mixture was incubated at 20°C for up to 1 h. The pore-forming 
activity was monitored after the dialysis step and after various periods 
of incubation with hydroxylamine. 
2.6. Modification with citraconic anhydride 
Treatment of amoebapore with citraconic anhydride was performed 
according to Atassi and Habeeb [15]. Amoebapore (5 PM) was dis- 
solved in 50 mM sodium phosphate buffer, pH 8.5. Citraconic anhy- 
dride was added dropwise from a freshly prepared stock solution in 
anhydrous ethanol to reach a final concentration of 1 mM. The mixture 
was allowed to react for 1 h at 20°C. Aliquots were taken at different 
time intervals and their pore-forming activity was monitored. 
2.7. Reversal of citraconic anhydride modification by treatment with HCI 
Modified amoebapore (5 PM) was dialyzed against 50 mM sodium 
phosphate buffer, pH 8.5, to remove remaining citraconic anhydride. 
After dialysis the pore-forming activity of the sample was determined. 
HCI was added dropwise to the modified amoebapore to adjust the pH 
to 4. The mixture was incubated at 37°C and aliquots were removed 
at different time intervals to determine their pore-forming activity. 
2.8. Modification with manoalide 
Manoalide [16,17] was added from a 3 mM stock solution in anhy- 
drous ethanol to an amoebapore solution (5 ,uM) in 50 mM sodium 
phosphate buffer, pH 8.5, to reach a final concentration of 125 PM 
(unless otherwise specified). Subsequently, the reaction mixture was 
incubated for up to 1 h at 20°C. Aliquots were taken at different time 
intervals to measure their pore-forming activity. 
2.9. Amino acid analysis 
Peptide samples (100 pmol) were hydrolized in 6 M HCl, 1% phenol 
at 110°C for 20 h in vacua and subjected to amino acid analysis (421 
amino acid analyzer; Applied biosystems) 
2.10. Enzyme-linked immunosorbent assay (ELISA) 
The assay was performed in radiated, flat-bottom microtiter plates 
(F-plates; Greiner, Germany). The wells of the plates were coated with 
various concentrations of the peptides in 100 mM sodium carbonate 
buffer, pH 9.5, for 12 h at 4’C followed by blocking with 5% milk 
powder in phosphate-buffered saline (PBS) for 30 min at 20°C. Subse- 
quently, the plates were incubated with rabbit antiserum to 
amoebapore [5] at a 1: 100 dilution in 2.5% milk powder in PBS for 2 h 
at 20°C. After three washes with PBS containing 0.1% Tween 20, the 
plates were incubated with an anti-rabbit immunoglobulin antibody- 
peroxidase conjugate (Dako, Denmark) for 2 h at 20°C, washed with 
PBS/Tween, and the assay was developed using o-phenylendiamine and 
H202 as substrates. The resulting colour reaction was stopped with 2 M 
sulfuric acid after 2-5 min and the absorbance at 492 nm was measured 
with an ELISA plate reader (Titertek Multiskan PluslMK II; ICN 
Flow). 
2.11. Gel-electrophoresis and blotting 
Tricine-SDS/PAGE [18] in 13% separation gels and subsequent im- 
munoblotting were carried out as described [5]. 
2.12. Association of peptides with Iiposomes 
Natural and modified amoebapore (5 PM) was diluted ten times in 
liposome buffer (50 mM Tris maleate, 50 mM potassium sulfate, 0.5 
mM ethylenediamine t traacetic acid, 0.02% sodium azide), adjusted 
with KOH to various pH, and incubated with vesicles of mixed soybean 
phospholipids for 1 h at 4°C by permanently shaking. These liposomes 
were prepared by dissolving dry phospholipids in chloroform (1 mg/ 
ml), the solvent was evaporated under a stream of argon and the lipids 
were stored under vacuum overnight; the phospholipids were resus- 
pended in the same volume of liposome buffer, pH 5.2, by vortex 
mixing. After the incubation period, liposomes and liposome-associ- 
ated peptides were separated from peptides in solution by centrifuga- 
tion at 24 psi (= 100,000 x g) for 30 min using an Beckmann airfuge 
centrifuge. The resulting pellet was washed with liposome buffer, and 
supematant and washes were subjected to the ELISA. Since the washes 
showed absorbance always <5% of that of the supematants, in the 
following only absorbance values of the latter represent peptides not 
associated with liposomes. These values were expressed as the percent- 
Fig. 1. a-Helical net diagram of the amoebapore sequence. The four predicted a-helical regions are represented as opened and flattened cylinders 
viewed from the side. Residues are displayed therein to give approximately 3.6 residues per turn of the helix. Positively charged residues are highlighted 
by bold-faced letters. The one-letter notation of amino acids is used. 
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age of the values of the controls, i.e. the same peptides adsorbed irectly 
to the microtiter plates. 
2.13. Crosslinking of liposome-associated peptides 
Sedimented liposomes and liposome-associated peptides were 
washed and resuspended in 50 mM sodium phophate buffer, pH 7.0. 
For crosslinking interacting peptides, DSP [19] was added from a 
freshly prepared stock solution in dimethylsulfoxide to reach a final 
concentration of 100 PM. After 30 min at 20°C the reaction was 
stopped by adding an excess of Tris, and eventually the sample was 
subjected to Tricine-SDS/PAGE and immunoblotting. 
3. Results and discussion 
3. I. Pore-forming activity 
Chemical modification is a widely used method to study the 
role of amino acid residues for the function of peptides and 
proteins [2&22]. Since cationic residues were considered criti- 
cal for the pore-forming activity of amoebapore, we used vari- 
ous reagents for modifying these residues: (i) DEPC at pH 8.5 
to modify both, histidine and lysines; (ii) the same reagent at 
pH 6.0 to specifically modify histidine; and (iii) citraconic anhy- 
dride or manoalide to modify lysines only. All of the treatments 
resulted in nearly complete loss of pore-forming activity (Fig. 
2). The activity of histidine- as well as lysine-modified 
amoebapore was virtually restored by reversal of the chemical 
modifications (Fig. 2) indicating that the ffects observed were 
not due to irreversible side reactions or peptide denaturation. 
Whereas DEPC at pH 6.0 specifically modifies histidine [14], 
at higher pH a variety of residues, such as lysines, arginines, 
cysteines, tyrosines, and tryptophanes, are targets for side reac- 
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Fig. 2. Effects of chemical modifications and of their reversal on the 
pore-forming activity of amoebapore. Pore-forming activity was deter- 
mined by measuring the dissipation of a liposome membrane potential. 
As controls, amoebapore samples were incubated without modifying 
reagents. Amoebapore was treated with DEPC at pH 6.0 (A) and pG 
8.5 (& to suecifically modify the histidine residue and histidine DIUS 
lysine residues, respectively. Citraconic anhydride (o), and manoahde 
(+) were used to modify lysine residues only. The loss of activity during 
incubation with modifying reagents is shown as a function of time. 
(Inset) Pore-forming activity was virtually restored by reversal of mod- 
ifications. The histidine-modified amoebapore (A), treated with DEPC 
at pH 6.0, was reconstituted by hydroxylamine. Lysine-modified 
amoebapore (o), treated with citraconic anhydride, was reconstituted 
by addition of HCl. Experiments were done in duplicate. 
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Fig. 3. Correlation between inhibition of pore formation and the num- 
ber of lysine residues modified. Aliquots of amoebapore (5 PM) were 
incubated for 1 h at 20°C in the presence of various concentrations of 
manoalide. For each sample the residual pore-forming activity was 
measured by liposome depolarization. The percent inhibition of activity 
was calculated from the values obtained after incubation of 
amoebapore with or without manoalide under the same conditions. The 
number of modified lysine residues was determined by subjecting the 
samples to amino acid analysis and comparing the data for the manoal- 
ide-treated samples to those for the untreated control. Residues other 
than lysines were not found to be affected. Experiments were done in 
duplicate. 
tions [ 14,20,23]. Since amoebapore does not contain any argin- 
ine and tryptophane residues and the six cysteine residues of 
the peptide are all involved in disulfide bonds [6], the candidate 
residues affected by DEPC treatment at pH 8.5 in addition to 
histidine and lysines can be limited to the single tyrosine resi- 
due. Citraconic anhydride [15] and manoalide [16,17] are 
known to be specific for primary amino groups and their inhib- 
iting effects on pore formation strengthen the notion that lysine 
residues are critical for the peptide’s activity. In particular ma- 
noalide, a sesterterpenoid from the marine sponge Luffariella 
variabilis [24], is known to react irreversible with lysine residues 
and therefore is suitable to determine the number of residues 
modified by amino acid analysis [16,17]. Treatment of 
amoebapore with various amounts of this reagent revealed that 
the resulting loss of pore-forming activity correlates with the 
number of lysine residues modified (Fig. 3). The peptide lost 
50% of its activity when four of its eight lysine residues were 
affected by an equimolar amount of manoalide (relative to the 
primary amino groups present) as evidenced by amino acid 
analysis. A fivefold molar excess of the reagent results in a 
considerably more pronounced inhibition but led to the modi- 
fication of one additional lysine only. This finding suggests that 
the residual three lysine residues are not accessible to modifica- 
tion by manoalide. Since most of the treatments affect primary 
amino groups we can not exclude the possibility that the a- 
amino group of the N-terminus is modified also. However, 
modifications of residues other than lysines including the N- 
terminal glycine were not detected by amino acid analysis, amd 
the aforementioned results suggest hat the modification of the 
N-terminus is negligible. 
3.2. Effects of pH 
The remarkable effects of the chemical modifications sug- 
gested that the interaction of amoebapore with negatively 
charged phospholipids via its cationic residues is impaired. To 
test this assumption, the association of natural amoebapore 
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Fig. 4. Effect of pH on liposome association and pore formation. 
Liposome association was determined by measuring the amount of 
non-adsorbed amoebapore after incubation of the peptide (0.5 PM) 
with liposomes for 1 h at 4°C using an ELISA with anti-amoebapore. 
Pore-forming activity of amoebapore (0.5 ,uM) was determined by 
measuring liposome depolarization. Both properties at pH 5.2 were set 
as 100%. Experiments were done in duplicate. 
with membranes of liposomes, i.e. its binding and insertion, was 
measured in comparison to its pore-forming activity at various 
pHs. When pH was raised and hence the cationic side chains 
of the peptide were deprotonated, the percentage of membrane- 
associated peptide diminished, but the decrease in membrane 
association did not coincide with that in pore formation (Fig. 
4). On the contrary, a considerable discrepancy in the pH de- 
pendence was found between these two properties; e.g. whereas 
the majority of molecules were associated with liposomes at pH 
6.0, pore formation was found here to be virtually abolished. 
This finding suggests that, in addition to the interaction of 
amoebapore with phospholipids, another event involved in 
pore formation, probably the peptide-peptide interaction, is 
affected by raising the pH. Consequently, we investigated sep- 
arately the effects of the aforementioned chemical modifica- 
tions on membrane association and self-assembly of 
amoebapore. 
3.3. Membrane association 
To estimate the effects of histidine and lysine modifications 
on the ability of amoebapore to associate with membranes, we 
measured by ELBA the amount of modified peptide which was 
not bound to phospholipid vesicles compared to that of natural 
amoebapore. In preliminary experiments it became vident that 
the treatment of amoebapore with the modifying reagents al- 
tered its reactivity with anti-amoebapore to a different extent 
(Fig. 5). Whereas the lysine-modified peptides are considerably 
less reactive than the natural amoebapore in the ELBA, the 
histidine-modified peptide was readily recognized by the antis- 
erum, most likely because just one residue is affected. To rule 
out any influence that would be due to those differences in 
reactivity with anti-amoebapore or to a variability in binding 
to microtiter plates, the corresponding modified peptide was 
used as a control in each assay. 
When the single histidine residue was modified by treatment 
of amoebapore with DEPC at pH 6.0, approximately 70% of 
the molecules were still found to be associated with liposomes 
(Fig. 6). The same reagent has a remarkable ffect on the ability 
of the peptide to associate with the lipid vesicles at pH 8.5, at 
which it leads to neutralization of all cationic residues, suggest- 
ing that lysine residues play the major role in membrane inter- 
action compared to histidine. The inhibiting effect on lipid 
association is even more pronounced when lysine residues were 
modified specifically by treatment with citraconic anhydride or 
manoalide. Here one has to bear in mind that these reagents 
in contrast to DEPC convert the charge of the lysine residues. 
The newly generated negative charges may repulse the peptide 
from its preferred targets, the negatively charged phospholip- 
ids. 
3.4. Self-assembly 
Natural amoebapore tends to undergo self-association, par- 
ticularly after insertion into a membrane, suggesting peptide- 
peptide interactions relevant for pore formation [5]. Since his- 
tidine modification hardly diminished the ability of 
amoebapore to interact with phospholipids but abrogated its 
pore-forming activity, we examined whether the molecular or- 
ganization of the peptide after its association to liposomes is 
affected by this treatment. 
After incubation with liposomes and crosslinking with DSP, 
natural amoebapore formed homooligomers that were detected 
by immunoblotting as reactive higher-molecular mass entities 
(Fig. 7). The self-association is reversible since without 
crosslinking the peptide showed monomeric behaviour upon 
SDS/PAGE. The same experiment performed with histidine- 
modified amoebapore revealed that a large amount of the pep- 
tide was in the monomeric state after crosslinking and appeared 
to form oligomers to a much lesser extent. Although the migra- 
tion behaviour of the amoebapore monomer upon SDS/PAGE 
do not represent its actual molecular mass, it may be estimated 
from the immunoblot analysis that natural peptide oligomer- 
ized at least up to hexamers whereas the histidine-modified 
amoebapore appeared to preferentially form smaller entities. 
To explain the seemingly uncomplete prevention of self-assem- 
bly by the histidine modification, it is worth noting that 
amoebapore is known to aggregate also to some extent in solu- 
0 
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Fig. 5. ELISA calibration for natural and modified amoebapore. Serial 
dilutions of peptides were measured for absorbance after reaction with 
anti-amoebapore. Ooen symbols represent amoebapore incubated 
without reagent at pfi 6.0 in) or pH 8.5 (0). Filled symbols represent 
amoebanore treated with DEPC at oH 6.0 (A). DEPC at DH 8.5 (m). . ,, . ,. 
citracon~c anhydride (0) or manoalide (a) for 30 min. Experiments were 
done in duplicate. 
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tion [5]. It may be argued that either in such spontaneously 
formed oligomers the peptide is not accessible for the action of 
DEPC, or preformed oligomers are stable even after histidine 
modification. The virtually total loss of activity indicates that 
DEPC-treated amoebapore cannot form a transmembrane 
channel although oligomers exist. This implies either that oli- 
gomers do not insert into membranes, i.e. do not form pores, 
or, if the peptide does insert, in whatever state it is in, that a 
critical size of the oligomers has to be reached to be active 
which is inhibited by the histidine modification. 
The finding that histidine is implicated in the self-association 
of amoebapore is in good agreement with results of analogous 
functional studies on the a-toxin from Staphylococcus aureus 
[24] and on aerolysin from Aeromonas hydrophila [25,26]. For 
these pore-forming toxins, it was shown by chemical modifica- 
tion with DEPC or by site-directed mutagenesis that histidine 
residues are crucial for the oligomerization process. The signif- 
icance of the single histidine residue at position 75 for the 
function of amoebapore is emphasized by the recent finding 
that, in cytoplasmic granules of the amoebae, two additional 
isoforms of amoebapore exist, in which this residue is con- 
served despite considerable sequence divergence [27]. The num- 
ber of all other cationic residues in the three isoforms are 
virtually the same, but varied in their positions. 
The results presented here may have implications as to the 
mode of action of amoebapore. According to the barrel stave 
model we suggest that (i) amoebapore binds to negatively 
charged phospholipids via its protonated lysine residues; (ii) the 
negative membrane potential of the target membrane drives the 
peptide into the lipid bilayer; and (iii) self-assembly of the 
peptide occurs within the membrane to form the ion channel. 
In the last step His75 may play a direct role in the interaction 
with another monomer via its involvement in hydrogen bonds. 
Fig. 6. Association of natural and modified amoebapore with li- 
posomes. Liposome association was estimated by detecting unbound 
peptide with anti-amoebapore by ELISA after allowing the peptides 
(0.5 ,uM) to interact with phospholipid vesicles for 1 h at 4°C. Whereas 
the untreated amoebapore is represented by the open bar, modification 
of histidine and lysine residues is indicated by shaded and filled bars, 
respectively; the darker shading indicates that all cationic residues were 
modified. The modifying reagent is shown underneath each column; 
DEPC was used at pH 6.0 or pH 8.5. As controls, the same materials 
were adsorbed directly to the ELISA plates. Experiments were done in 
triplicate. 
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Fig. 7. Reversible oligomerization of natural amoebapore (AP) and 
histidine-modified amoebapore (AP-His) associated with liposomes. 
Peptide (0.5 PM) was allowed to interact with phospholipid vesicles for 
1 h at 4°C and aliquots of the mixture (0.4 pug peptide) were subjected 
to immunoblot analysis with anti-amoebapore. Comparison of the 
same material with (+) and without (-) crosslinking after membrane 
association using DSP reveals that the histidine-modified peptide exists 
primarily in its monomeric state, whereas the natural peptide had nearly 
exclusively formed homooligomers of higher molecular mass. 
Alternatively, the histidine residue may be important in stabiliz- 
ing the predicted fourth a-helix, as experiments with synthetic 
peptides suggest [28] and it would thereby rather indirectly 
promote oligomerization. We have to admit that it can not be 
deduced from our data whether a variable number of prein- 
serted monomers assemble after lateral diffusion in the phos- 
pholipid bilayer, as proposed, or oligomerization primarily oc- 
curs prior to insertion into the membrane. 
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